Research and Markets has announced the addition of the "Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2016" report to their offering.
Neuromyelitis Optica (Devic's Syndrome) - Neuromyelitis Optica (NMO), also known as Devic's disease, is an uncommon neurological condition caused by disease or damage to the brain, spinal cord or nerves. NMO is an autoimmune condition which means a person's immune system (the body's natural defense again infection) reacts abnormally and attacks tissues and organs in the body. In cases of NMO, the immune system attacks the myelin sheath. Symptoms include loss of vision, weakness, numbness and bladder/bowel problems.
Neuromyelitis Optica (Devic's Syndrome) pipeline therapeutics constitutes close to 19 molecules, out of which approximately 17 molecules are developed by Companies and the remaining by the Universities/Institutes. The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 4, 4, 2 and 7, respectively. Similarly, the Universities portfolio in Phase I and Discovery stages comprises 1 and 1 molecules, respectively.
Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Neuromyelitis Optica (Devic's Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in therapeutic development for Neuromyelitis Optica (Devic's Syndrome) and features dormant and discontinued projects.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/98cz5k/neuromyelitis.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161018006674/en/Business Wire
Last updated on: 18/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.